Aclaris Therapeutics, Inc. (ACRS)
3.75
-0.05
(-1.32%)
USD |
NASDAQ |
Apr 07, 16:00
3.99
+0.24
(+6.40%)
After-Hours: 04:00
Aclaris Therapeutics Shareholders Equity (Quarterly) : 103.08M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 199.74M |
| PMV Pharmaceuticals, Inc. | 104.71M |
| Atea Pharmaceuticals, Inc. | 275.43M |
| Instil Bio, Inc. | 113.87M |
| Corcept Therapeutics, Inc. | 647.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.46M |
| Total Liabilities (Quarterly) | 57.38M |
| Debt to Equity Ratio | 0.0205 |
| Current Ratio | 3.362 |
| Net Debt Paydown Yield | 0.03% |